\uff5e \u76ae\u819a\u79d1\u9818\u57df\u306e\u533b\u85ac\u54c1\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u30ea\u30fc\u30c0\u30fc\u3068\u3057\u3066\u3001
\n\u3088\u308a\u52b9\u679c\u7684\u306b\u533b\u7642\u30b3\u30df\u30e5\u30cb\u30c6\u30a3\u3068\u95a2\u308f\u308a\u306a\u304c\u3089\u3001\u60a3\u8005\u306eQOL\u5411\u4e0a\u3092\u76ee\u6307\u3057\u3066\u65b0\u305f\u306a\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u306b\u53d6\u308a\u7d44\u3080\u3000\uff5e<\/p>\n
<\/p>\n
2022\u5e745\u670827\u65e5<\/p>\n
Veeva Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
Veeva Systems\u3010NYSE:VEEV\u3011\uff08\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : Sebastian Bather\u3001\u4ee5\u4e0b Veeva\uff09\u306f\u3001\u76ae\u819a\u79d1\u9818\u57df\u306e\u533b\u85ac\u54c1\u30b0\u30ed\u30fc\u30d0\u30eb\u30ea\u30fc\u30c0\u30fc\u3067\u3042\u308bLEO Pharma<\/a><\/strong>\u793e\u3068\u306e\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3092\u62e1\u5927\u3057\u305f\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002LEO Pharma\u793e\u306f\u3001Veeva Link\u306e\u30c7\u30fc\u30bf\u88fd\u54c1\u7fa4\u306e\u3072\u3068\u3064\u3067\u3042\u308b\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u306e\u30a4\u30f3\u30c6\u30ea\u30b8\u30a7\u30f3\u30b9\u3092\u63d0\u4f9b\u3059\u308b\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3Veeva Link for Key People<\/a><\/strong>\u3092\u4f7f\u7528\u3057\u3066\u3001\u533b\u79d1\u5b66\u5c02\u9580\u5bb6\u306e\u30b3\u30df\u30e5\u30cb\u30c6\u30a3\u3067\u6709\u7528\u306a\u8b70\u8ad6\u3092\u4fc3\u9032\u3057\u3066\u3044\u304d\u307e\u3059\u3002LEO Pharma\u793e\u306e\u30e1\u30c7\u30a3\u30ab\u30eb\u30a2\u30d5\u30a7\u30a2\u30fc\u30ba\u90e8\u9580\u3068\u30bb\u30fc\u30eb\u30b9\u90e8\u9580\u306f\u3001Link for Key People\u3092\u6d3b\u7528\u3059\u308b\u3053\u3068\u3067\u3001\u76ae\u819a\u79d1\u9818\u57df\u306e\u533b\u79d1\u5b66\u5c02\u9580\u5bb6\u3068\u306e\u30a8\u30f3\u30b2\u30fc\u30b8\u30e1\u30f3\u30c8\u3092\u62e1\u5927\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001Veeva\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f\u3053\u3061\u3089<\/strong><\/a>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n <\/p>\n LEO Pharma\u793e\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u30d5\u30a3\u30fc\u30eb\u30c9\u30e1\u30c7\u30a3\u30ab\u30eb\u30a8\u30af\u30bb\u30ec\u30f3\u30b9\u62c5\u5f53\u30b7\u30cb\u30a2\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3067\u3042\u308bJoshua Corriveau\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u5f53\u793e\u306f\u3001\u76ae\u819a\u79d1\u9818\u57df\u306e\u6a19\u6e96\u6cbb\u7642\u306e\u5411\u4e0a\u306b\u52aa\u3081\u3066\u304a\u308a\u3001\u4e16\u754c\u4e2d\u306e\u79d1\u5b66\u3001\u30c7\u30b8\u30bf\u30eb\u3001\u30af\u30ea\u30cb\u30ab\u30eb\u306e\u5206\u91ce\u306e\u30ea\u30fc\u30c0\u30fc\u304b\u3089\u6700\u65b0\u306e\u77e5\u898b\u3092\u5f97\u308b\u3053\u3068\u306f\u304d\u308f\u3081\u3066\u91cd\u8981\u306a\u3053\u3068\u3067\u3059\u3002\u79c1\u305f\u3061\u304c\u76ae\u819a\u79d1\u9818\u57df\u3067\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u8d77\u3053\u3059\u305f\u3081\u306b\u306f\u3001\u95a2\u9023\u3059\u308b\u7814\u7a76\u958b\u767a\u306e\u6700\u524d\u7dda\u306b\u3044\u308b\u5c02\u9580\u5bb6\u306b\u95a2\u3057\u3066\u3001\u6b63\u78ba\u3067\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30c7\u30fc\u30bf\u3092\u5f97\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002Link for Key People\u306f\u3001\u65e2\u77e5\u306e\u5c02\u9580\u5bb6\u3068\u306e\u95a2\u4fc2\u3092\u6df1\u3081\u3001\u3055\u3089\u306b\u306f\u65b0\u305f\u306a\u5c02\u9580\u5bb6\u3092\u7279\u5b9a\u3057\u3066\u3001\u60a3\u8005\u30b1\u30a2\u3092\u9032\u6b69\u3055\u305b\u308b\u533b\u79d1\u5b66\u5c02\u9580\u5bb6\u3068\u306e\u60c5\u5831\u4ea4\u63db\u306e\u4fc3\u9032\u306b\u5f79\u7acb\u3061\u307e\u3059\u3002\u300d<\/p>\n \u4eca\u5f8c2\uff5e3\u5e74\u6bce\u306b\u65b0\u85ac\u306e\u4e0a\u5e02\u3092\u8a08\u753b\u3057\u3066\u3044\u308bLEO Pharma\u793e\u306e\u30e1\u30c7\u30a3\u30ab\u30eb\u30a2\u30d5\u30a7\u30a2\u30fc\u30ba\u90e8\u9580\u306f\u3001\u4e16\u754c\u4e2d\u306e\u533b\u79d1\u5b66\u5c02\u9580\u5bb6\u3068\u306e\u30a8\u30f3\u30b2\u30fc\u30b8\u30e1\u30f3\u30c8\u306b\u304a\u3044\u3066\u91cd\u8981\u306a\u5f79\u5272\u3092\u62c5\u3063\u3066\u3044\u307e\u3059\u3002\u5404\u5c02\u9580\u5bb6\u306b\u95a2\u3057\u3066\u3088\u308a\u6df1\u304f\u7406\u89e3\u3059\u308b\u3053\u3068\u306b\u3088\u3063\u3066\u3001\u9032\u5316\u3057\u7d9a\u3051\u308b\u30d8\u30eb\u30b9\u30b1\u30a2\u30a8\u30b3\u30b7\u30b9\u30c6\u30e0\u306e\u4e2d\u3067\u3001\u5bfe\u9762\u304a\u3088\u3073\u30c7\u30b8\u30bf\u30eb\u3067\u306e\u30a8\u30f3\u30b2\u30fc\u30b8\u30e1\u30f3\u30c8\u3092\u5145\u5b9f\u3055\u305b\u308b\u3053\u3068\u304c\u53ef\u80fd\u306b\u306a\u308a\u307e\u3059\u3002Link\u306fVeeva CRM<\/a><\/strong>\u3068\u30b7\u30fc\u30e0\u30ec\u30b9\u306b\u7d71\u5408\u3055\u308c\u3066\u304a\u308a\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u304a\u3088\u3073\u30ed\u30fc\u30ab\u30eb\u3067\u306e\u533b\u5b66\u4f1a\u3001\u81e8\u5e8a\u8a66\u9a13\u3001\u30c7\u30b8\u30bf\u30eb\u30a8\u30f3\u30b2\u30fc\u30b8\u30e1\u30f3\u30c8\u6d3b\u52d5\u306a\u3069\u3001\u5e45\u5e83\u3044\u30bd\u30fc\u30b9\u304b\u3089\u91cd\u8981\u306a\u30a4\u30f3\u30b5\u30a4\u30c8\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002<\/p>\n Veeva Link\u306e\u30b8\u30a7\u30cd\u30e9\u30eb\u30de\u30cd\u30fc\u30b8\u30e3\u30fc\u3067\u3042\u308bKilian Weiss\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300cLEO Pharma\u793e\u306e\u6025\u901f\u306a\u30af\u30ea\u30cb\u30ab\u30eb\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u306e\u30da\u30fc\u30b9\u3092\u9451\u307f\u308c\u3070\u3001\u540c\u793e\u306e\u30e1\u30c7\u30a3\u30ab\u30eb\u30a2\u30d5\u30a7\u30a2\u30fc\u30ba\u90e8\u9580\u3068\u30bb\u30fc\u30eb\u30b9\u90e8\u9580\u304c\u6b63\u78ba\u306a\u30a8\u30f3\u30b2\u30fc\u30b8\u30e1\u30f3\u30c8\u3092\u884c\u3063\u3066\u3044\u308b\u5148\u99c6\u7684\u5b58\u5728\u3067\u3042\u308b\u306e\u3082\u4e0d\u601d\u8b70\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002LEO Pharma\u793e\u306e\u30e1\u30c7\u30a3\u30ab\u30eb\u30a2\u30d5\u30a7\u30a2\u30fc\u30ba\u90e8\u9580\u3068\u30bb\u30fc\u30eb\u30b9\u90e8\u9580\u306f\u3001Veeva\u306e\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u306e\u30ab\u30b9\u30bf\u30de\u30fc\u30a4\u30f3\u30c6\u30ea\u30b8\u30a7\u30f3\u30b9\u3092\u6d3b\u7528\u3057\u3001\u4e3b\u8981\u306a\u30ea\u30fc\u30c0\u30fc\u306e\u5b66\u8853\u7684\u30bb\u30f3\u30c1\u30e1\u30f3\u30c8\u3084\u5c02\u9580\u5bb6\u306e\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u3092\u628a\u63e1\u3059\u308b\u3053\u3068\u306b\u3088\u308a\u3001\u30ad\u30fc\u30d1\u30fc\u30bd\u30f3\u3068\u52b9\u679c\u7684\u306b\u30b3\u30df\u30e5\u30cb\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u53d6\u308a\u3001\u60a3\u8005\u306eQOL\u3092\u5411\u4e0a\u3055\u305b\u308b\u3053\u3068\u304c\u53ef\u80fd\u306b\u306a\u308a\u307e\u3059\u3002\u300d<\/p>\n LEO Pharma\u793e\u306f\u3059\u3067\u306bVeeva Commercial Cloud<\/a><\/strong>\uff08\u30de\u30eb\u30c1\u30c1\u30e3\u30cd\u30eb\u30a8\u30f3\u30b2\u30fc\u30b8\u30e1\u30f3\u30c8<\/a><\/strong>\u3001\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u30b3\u30f3\u30c6\u30f3\u30c4\u7ba1\u7406<\/a><\/strong>\u3001\u30e1\u30c7\u30a3\u30ab\u30eb\u30b3\u30f3\u30c6\u30f3\u30c4\u7ba1\u7406<\/a><\/strong>\u306e\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3092\u542b\u3080\uff09\u3092\u6d3b\u7528\u3057\u3066\u3044\u307e\u3059\u304c\u3001\u305d\u3053\u306bLink for Key People\u304c\u8ffd\u52a0\u3055\u308c\u307e\u3059\u3002\u307e\u305f\u540c\u793e\u306f\u3001Veeva Digital Trials Platform<\/a><\/strong>\u306e\u30a2\u30fc\u30ea\u30fc\u30a2\u30c0\u30d7\u30bf\u30fc\u3067\u3059\u3002\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u304c\u533b\u7642\u95a2\u9023\u306e\u30a2\u30af\u30c6\u30a3\u30d3\u30c6\u30a3\u306e\u5f71\u97ff\u306b\u95a2\u3059\u308b\u7406\u89e3\u3092\u6df1\u3081\u3001\u65b0\u305f\u306a\u5c02\u9580\u5bb6\u3084\u533b\u7642\u5f93\u4e8b\u8005\u3092\u7279\u5b9a\u3057\u3066\u3064\u306a\u304c\u308a\u3001\u3088\u308a\u6709\u610f\u7fa9\u3067\u30d0\u30e9\u30f3\u30b9\u306e\u53d6\u308c\u305f\u30a8\u30f3\u30b2\u30fc\u30b8\u30e1\u30f3\u30c8\u3092\u4fc3\u9032\u3059\u308b\u305f\u3081\u306bLink for Key People\u304c\u3069\u306e\u3088\u3046\u306b\u5f79\u7acb\u3064\u304b\u3001\u305d\u306e\u8a73\u7d30\u306b\u3064\u3044\u3066\u306f\u3001veeva.com\/jp\/VeevaLink<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n Veeva Link\u306f\u3001\u5171\u901a\u306e\u30c7\u30fc\u30bf\u30a2\u30fc\u30ad\u30c6\u30af\u30c1\u30e3\u4e0a\u306b\u69cb\u7bc9\u3055\u308c\u305f\u30c7\u30fc\u30bf\u88fd\u54c1\u30b9\u30a4\u30fc\u30c8\u3067\u3042\u308bVeeva Data Cloud<\/a><\/strong>\u306e\u4e00\u90e8\u3067\u3059\u3002<\/p>\n <\/p>\n \u3010<\/strong>Veeva Systems<\/strong>\u793e\u306b\u3064\u3044\u3066\u3011<\/strong> \u3010Forward-looking Statements<\/strong>\u3011<\/strong> LEO Pharma\u793e\u306e\u30b3\u30e1\u30f3\u30c8\uff1aLink for Key People\u306f\u3001\u65e2\u77e5\u306e\u5c02\u9580\u5bb6\u3068\u306e\u95a2\u4fc2\u3092\u6df1\u3081\u3001\u3055\u3089\u306b\u306f\u65b0\u305f\u306a\u5c02\u9580\u5bb6\u3092\u7279\u5b9a\u3057\u3066\u3001\u60a3\u8005\u30b1\u30a2\u3092\u9032\u6b69\u3055\u305b\u308b\u533b\u79d1\u5b66\u5c02\u9580\u5bb6\u3068\u306e\u60c5\u5831\u4ea4\u63db\u306e\u4fc3\u9032\u306b\u5f79\u7acb\u3061\u307e\u3059\u3002<\/p>\n","protected":false},"author":131,"featured_media":47177,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322,341],"tags":[],"class_list":["post-47196","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-release","category-case-study"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/47196"}],"collection":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=47196"}],"version-history":[{"count":7,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/47196\/revisions"}],"predecessor-version":[{"id":47207,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/47196\/revisions\/47207"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/media\/47177"}],"wp:attachment":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=47196"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=47196"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=47196"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nVeeva Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u5411\u3051\u306b\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u30671,100\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u306b\u3001\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u306b\u30b3\u30df\u30c3\u30c8\u3059\u308b\u69d8\u3005\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u30d1\u30d6\u30ea\u30c3\u30af\u30fb\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u30fb\u30b3\u30fc\u30dd\u30ec\u30fc\u30b7\u30e7\u30f3\u4f01\u696d\u3068\u3057\u3066Veeva\u306f\u3001\u9867\u5ba2\u3084\u5f93\u696d\u54e1\u3001\u63d0\u643a\u4f01\u696d\u3001\u682a\u4e3b\u3001\u30b5\u30fc\u30d3\u30b9\u63d0\u4f9b\u696d\u754c\u3092\u542b\u3080\u3059\u3079\u3066\u306e\u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc\u306e\u5229\u76ca\u30d0\u30e9\u30f3\u30b9\u3092\u4fdd\u3064\u3053\u3068\u306b\u30b3\u30df\u30c3\u30c8\u3057\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001veeva.com\/jp<\/a>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements regarding Veeva\u2019s products and services and the expected results or benefits from use of our products and services. Such statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-K for the period ended January 31, 2022, which you can find here<\/a> (a summary of risks which may impact our business can be found on pages 13 and 14), and in our subsequent SEC filings, which you can access at sec.gov<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"